lithium has been researched along with Amyotrophic Lateral Sclerosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dardery, NM; Attia, AN; Hamad, AA; Meshref, M; Mohamed, SF | 1 |
| Giakalou, VV; Giotakos, O; Nisianakis, P; Tsouvelas, G | 1 |
| Arranz-Tagarro, JA; Galán, L; García, AG; Gómez-Pinedo, U; Guerrero, A; Martínez-Vila, E; Matías-Guiu, J; Vela, A; Viña, D; Yáñez, M | 1 |
| Feng, HL; Jiang, HQ; Jiang, HZ; Qi, Y; Wang, J; Wang, SY; Wang, TH; Wang, XD; Wang, Y; Yang, YQ; Yin, X; Zhang, CT | 1 |
| Bartalucci, A; Cantafora, E; Ferrucci, M; Fornai, F; Fulceri, F; Longone, P; Nutini, M; Paparelli, A; Spalloni, A | 1 |
| Swash, M | 1 |
| Aggarwal, SP; Conwit, RA; Cudkowicz, M; Jackson, KE; Kaufman, P; McKinley, J; Pinto, H; Schoenfeld, D; Shefner, J; Simpson, E; Zinman, L | 1 |
| Saute, JA; Schestatsky, P; Valler, L | 1 |
| Audet, JN; Julien, JP; Soucy, G | 1 |
| Zaleska, B | 1 |
2 review(s) available for lithium and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Safety and efficacy of lithium in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis of randomized controlled trials.
Topics: Amyotrophic Lateral Sclerosis; Humans; Lithium; Randomized Controlled Trials as Topic; Valproic Acid; Vital Capacity | 2023 |
[Progress in the treatment of degenerative diseases of the nervous system. Selected problems].
Topics: Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Humans; Huntington Disease; Lithium; Neostigmine; Parkinson Disease; Penicillamine; Phthalazines; Selegiline; Tetrabenazine; Tiapamil Hydrochloride | 1980 |
1 trial(s) available for lithium and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Intention to Treat Analysis; Lithium; Male; Medical Futility; Middle Aged; Patient Selection; Prognosis; Riluzole; Treatment Outcome | 2010 |
7 other study(ies) available for lithium and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Lithium in the public water supply and suicide mortality in Greece.
Topics: Amyotrophic Lateral Sclerosis; Crime; Drinking Water; Female; Greece; Humans; Incidence; Lithium; Lithium Carbonate; Male; Retrospective Studies; Suicide | 2013 |
The neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by riluzole.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Survival; Excitatory Amino Acid Antagonists; Humans; Lithium; Memantine; Minocycline; Neurons; Neuroprotective Agents; Rats; Riluzole | 2014 |
Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid.
Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Cell Line; Genetic Predisposition to Disease; Homer Scaffolding Proteins; Humans; Lithium; Mice; Mice, Transgenic; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Superoxide Dismutase; Valproic Acid | 2016 |
A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium.
Topics: Amyotrophic Lateral Sclerosis; Animals; Axons; Biomarkers; Brain Mapping; Brain Stem; Choline O-Acetyltransferase; Cranial Nerves; Cytoprotection; Disease Models, Animal; Drug Administration Schedule; Facial Nerve; Humans; Hypoglossal Nerve; Lithium; Male; Mice; Mice, Transgenic; Motor Neurons; Nerve Degeneration; Neuroprotective Agents; Treatment Outcome; Trigeminal Nerve; Vagus Nerve | 2010 |
Lithium time-to-event trial in amyotrophic lateral sclerosis stops early for futility.
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Humans; Lithium; Medical Futility | 2010 |
The role of lithium in ALS remains unknown.
Topics: Amyotrophic Lateral Sclerosis; Antipsychotic Agents; Disease Progression; Lithium; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Blotting, Western; Disease Models, Animal; DNA-Binding Proteins; Drug Therapy, Combination; Enzyme Inhibitors; Immunohistochemistry; Lithium; Methylene Blue; Mice; Mice, Inbred C57BL; Mice, Transgenic; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2012 |